STAGREL-A & A75 Tablets

 Harbour a Pro Antithrombotic Activity to steer-clear Adverse CVD

COMPOSITION –

  • Stagrel-A: Clopidogrel 75 mg + Aspirin IP 150 mg
  • Starel-A75: Clopidogrel 75 mg + Aspirin IP 75 mg
Category:

Description

Clopidogrel 

  • Drug class: Antiplatelet medications
  • Clopidogrel is a prodrug, which needs to be metabolized in the liver into active metabolites.
  • Clopidogrel efficiently reduces ADP-induced platelet aggregation (a key phenomenon in atherosclerosis & CVD) and prolongs bleeding time and is a safe and efficacious antiplatelet drug

Aspirin 

  • Drug Class: NSAIDs
  • The most widely tested antiplatelet regimen was aspirin.The benefit of low-dose aspirin therapy for the secondary prevention of serious cardiovascular events is clear.
  • Aspirin has long been the therapeutic foundation of the secondary prevention of CVD, to which contemporary drugs such as statins, and other antithrombotics have been added.

Combination:

  • Aspirin and clopidogrel are antiplatelet agents that display good antithrombotic activity.Clopidogrel in combination with aspirin is the current “gold standard” for reducing cardiovascular events.
  • Clopidogrel plus aspirin can reduce the relative risk of adverse cardiovascular events by 20%, compared with aspirin alone.

Composition

  • Stagrel-A: Clopidogrel 75 mg + Aspirin IP 150 mg
  • Starel-A75: Clopidogrel 75 mg + Aspirin IP 75 mg